Issue: November/December 2016, Posted Date: 12/8/2016
Catalent Becomes First CDMO to Join Pharmaceutical Supply Chain Initiative
Catalent Pharma Solutions, the leading global provider
of advanced delivery technologies and development solutions for drugs,
biologics and consumer health products, recently announced that it had joined the
Pharmaceutical Supply Chain Initiative (PSCI).
The PSCI was set up in 2006 as a non-profit
organization to unite pharmaceutical and healthcare companies that share a
vision of better, social, environmental and economic outcomes in the
communities, sharing knowledge and expertise to drive complex, global change.
“We are proud to join some of the biggest names in the
pharmaceutical industry in the PSCI to promote responsible supply chain
management and better business conditions across the industry,” commented
Alessandro Maselli, Catalent’s Senior Vice President of Global Operations. He
continued, “Catalent operates as a global business, and it is through
international outreach initiatives such as the PSCI, where like-minded
companies come together, that we can demonstrate leadership in this critical
area and forge a long lasting, positive impact, not only on our business practices,
but the industry as a whole.”
Catalent recently announced the appointment of Ms.
Shannon Trilli as its Director of Corporate Responsibility, who, along with the
other members of the company’s Corporate Responsibility Council, oversees
Catalent’s existing initiatives in sustainability and maximizing social impact.
For more information on the PSCI, please visit https://pscinitiative.org/about
Catalent is the leading global provider of advanced
delivery technologies and development solutions for drugs, biologics and
consumer health products. With over 80 years serving the industry, Catalent has
proven expertise in bringing more customer products to market faster, enhancing
product performance and ensuring reliable clinical and commercial product
supply. Catalent employs approximately 9,500 people, including over 1,400
scientists, at more than 30 facilities across five continents, and in fiscal
2016 generated $1.85 billion in annual revenue. Catalent is headquartered in
Somerset, New Jersey. For more information, visit www.catalent.com.
This record has been viewed 440 times.